- New partnership with AI software provider Lunit to incorporate its chest detection suite into Philips’ diagnostic X-ray suite
- Latest release of Philips Digital Radiography and Fluoroscopy system (CombiDiagnost R90) receives FDA 510(k) clearance
Our partnership with Lunit to incorporate their diagnostic AI into our X-ray suite combines with a host of intelligent and streamlined workflow features in the Philips Radiography Unified User Interface (Eleva) across our digital radiography systems, enabling a smooth and efficient, patient-focused workflow.
Daan van Manen
General Manager for Diagnostic X-ray at Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Philips Global Press Office
Tel.: +31 631 639 916
You are about to visit a Philips global content page
You are about to visit the Philips USA website.
Philips Global Press Office
Tel.: +1 978-221-8919
You are about to visit a Philips global content page
You are about to visit the Philips USA website.
You are about to visit a Philips global content page
You are about to visit the Philips USA website.
You are about to visit a Philips global content page
You are about to visit the Philips USA website.